1,605 results on '"Langley, R."'
Search Results
2. P195 Vaping and cystic fibrosis: current perceptions and future directions
3. P043 The oxygen pulse response during cardiopulmonary exercise testing in our paediatric cystic fibrosis population
4. P044 Noisy breathing during exercise in a cystic fibrosis patient – What’s the cause?
5. Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for omalizumab: a single Center experience.
6. Radio Instrument Package for Lunar Ionospheric Observation: A Concept Study
7. Matthew Glover.
8. SEA approach applied to the estimation of the vibroacoustic response of a statistical system excited through a nonlinear device.
9. A linearised Hybrid FE-SEA analysis method for complex systems with nonlinearities under random excitation.
10. A Non-Poisson Model for the Vibration Analysis of Uncertain Dynamic Systems
11. A Transfer Matrix Analysis of the Energetics of Structural Wave Motion and Harmonic Vibration
12. 120 Safety of Guselkumab in Patients With Moderate to Severe Psoriasis: Pooled Analyses Across Clinical Studies
13. Statistical energy analysis of nonlinear vibrating systems
14. Nonlinear damping and quasi-linear modelling
15. An efficient model of drill-string dynamics with localised non-linearities
16. Universal eigenvalue statistics and vibration response prediction
17. A Power Absorbing Matrix for the Hybrid FEA-SEA Method
18. Oxygen desaturation indices as a predictor for obstructive sleep apnoea in children
19. Feasibility of wearable respiratory monitoring in paediatric sleep medicine: early insights
20. 782TiP Reduced frequency immune checkpoint inhibition in cancers (REFINE): A multi-arm phase II trial testing reduced intensity immunotherapy in different cancers
21. LBA62 Comparison of abiraterone acetate and prednisolone (AAP) or combination enzalutamide (ENZ) + AAP for metastatic hormone sensitive prostate cancer (mHSPC) starting androgen deprivation therapy (ADT): Overall survival (OS) results of 2 randomised phase III trials from the STAMPEDE protocol
22. LB946 Spesolimab controls chronic inflammation in GPP
23. Preschool wheeze: a role for antibiotics?: P85
24. SO-9 Pathological primary tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trials
25. SO-10 The prognostic role of microarchitecture in tumour-positive lymph nodes in oesophageal cancer patients: Results from the UK MRC OE02 trial
26. Low Risk of Serious Infections and Infections of Interest in Psoriasis Patients Treated with Guselkumab (GUS) for up to 5 Years in VOYAGE (VOY) 1&2 Phase 3 Trials
27. Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
28. Some Perspectives on Wave-Mode Duality in Sea
29. Wave Propagation Through Randomly Disordered Near-Periodic Structures
30. Supplement to: Secukinumab in plaque psoriasis — results of two phase 3 trials.
31. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
32. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
33. Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial
34. Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis
35. Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up
36. Determining receiver biases in GPS-derived total electron content in the auroral oval and polar cap region using ionosonde measurements
37. Bayesian parameter identification for vibro-acoustic models with nonparametric uncertainty
38. SO-6 Microarchitectural changes in regional lymph nodes after chemotherapy in oesophageal cancer: Results from the UK MRC OE02 trial
39. AB0528 COMPARABLE SAFETY PROFILE OF GUSELKUMAB IN PSORIATIC ARTHRITIS AND PSORIASIS: RESULTS FROM PHASE 3 TRIALS THROUGH 1 YEAR
40. Five-year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomised phase 3 clinical trials (reSURFACE 1 and reSURFACE 2)
41. Bimekizumab response maintenance through two years of treatment in patients with moderate to severe plaque psoriasis who responded after 16 weeks: Interim results from the BE BRIGHT open-label extension trial
42. Improved amplitude- and phase-scintillation indices derived from wavelet detrended high-latitude GPS data
43. Interference Cancellation in Body-Area Networks Using Linear Multiuser Receivers
44. Supplement to: 52-Week trial comparing briakinumab with methotrexate in patients with psoriasis.
45. SINR analysis of the subtraction-based SMI beamformer
46. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial
47. Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH
48. A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis
49. Publisher’s Note: “A generalization of the Lagrange–Hamilton formalism with application to non-conservative systems and the quantum to classical transition” [J. Math. Phys. 62, 033503 (2021)]
50. A generalization of the Lagrange–Hamilton formalism with application to non-conservative systems and the quantum to classical transition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.